A favorable alliance between repetitive use of levosimendan and advanced heart failure: Polish two-centered inpatient perspective in need of validation

Kardiol Pol. 2023;81(3):287-289. doi: 10.33963/KP.a2023.0034. Epub 2023 Feb 5.

Authors

Marcin Książczyk¹, Marcin Gruchała², Iwona Stopczyńska², Małgorzata Lelonek³

Affiliations

¹ Department of Noninvasive Cardiology, Medical University of Lodz, Łódź, Poland. marcin_ksiazczyk@interia.pl.
² 1st Department of Cardiology, Medical University of Gdansk, Gdańsk, Poland.
³ Department of Noninvasive Cardiology, Medical University of Lodz, Łódź, Poland.

PMID: 36739649
DOI: 10.33963/KP.a2023.0034

No abstract available

MeSH terms

Cardiotonic Agents / therapeutic use
Heart Failure* / drug therapy
Humans
Hydrazones
Inpatients
Poland
Pyridazines* / therapeutic use
Simendan / therapeutic use

Substances

Simendan
Cardiotonic Agents
Hydrazones
Pyridazines